Hearing statusCANCELLED: Hearing titleAuthorization for Investigation into the High Costs of Prescription Drugs and Related Subpoenas

Authorization for Investigation into the High Costs of Prescription Drugs for Patients in the United States Compared to Other Countries

Authorization for Subpoena of Joaquin Duato, Chief Executive Officer, Johnson & Johnson, for Testimony Relating to the Committee Investigation into the High Costs of Prescription Drugs for Patients in the United States Compared to Other Countries

Authorization for Subpoena of Robert Davis, Chief Executive Officer, Merck, for Testimony Relating to the Committee Investigation into the High Costs of Prescription Drugs for Patients in the United States Compared to Other Countries

Any additional business for consideration